CXI Healthcare Technology Group Limited Completes Third-Party Allotment of 5.5 Million Shares Resulting in 73% Dilution
CXI Healthcare Technology Group Limited completed the payment for a third-party allotment on July 9, 2026, issuing 5.5 million new shares. The actual gross proceeds were approximately 6.47 billion KRW, slightly lower than initially planned due to exchange rate fluctuations, with an issuance price of 1,176 KRW per share, a slight premium to the current market price of 1,064 KRW.
However, this massive capital increase adds 73% to the existing 7.47 million shares, diluting existing shareholders' ownership from 42.4% to 57.6%. The raised amount represents 81% of the pre-issuance market cap, putting significant pressure on the stock price.
The specific use of proceeds was not disclosed in this result filing, and the identity of the third-party allottees remains unknown, raising governance transparency concerns.
[AI Summary]CXI Healthcare Technology Group Limited has completed a capital increase causing a 73% dilution of existing shares. Although the issuance price is at a premium to market, the absolute dilution severely impairs shareholder value. The undisclosed use of funds and counterparty introduce high investment risk.
KOSDAQ Filing Information
Securities Issuance Result (Voluntary Disclosure) (Third-Party Allotment Rights Offering)
Company: CXI Healthcare Technology Group (900120)
Submission: CXI Healthcare Technology Group Limited